Loading...

William J Murphy

TitleProf
InstitutionUniversity of California Davis
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Withers SS, Moore PF, Chang H, Choi JW, McSorley SJ, Kent MS, Monjazeb AM, Canter RJ, Murphy W, Sparger EE, Rebhun RB. Multi-color flow cytometry for evaluating age-related changes in memory lymphocyte subsets in dogs. Dev Comp Immunol. 2018 May 31; 87:64-74. PMID: 29859828.
      View in: PubMed
    2. Canter RJ, Le CT, Beerthuijzen JMT, Murphy W. Obesity as an immune-modifying factor in cancer immunotherapy. J Leukoc Biol. 2018 May 15. PMID: 29762866.
      View in: PubMed
    3. McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, Fragoso RC, Valicenti RK, Canter RJ, Maverakis EM, Murphy W, Kelly K, Monjazeb AM. Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys. 2018 Apr 22. PMID: 29891204.
      View in: PubMed
    4. Aguilar EG, Murphy W. Obesity induced T cell dysfunction and implications for cancer immunotherapy. Curr Opin Immunol. 2018 Apr; 51:181-186. PMID: 29655021.
      View in: PubMed
    5. Kiuru M, Tartar DM, Qi L, Chen D, Yu L, Konia T, McPherson JD, Murphy W, Fung MA. Improving classification of melanocytic nevi: BRAF V600E expression associated with distinct histomorphologic features. J Am Acad Dermatol. 2018 Apr 10. PMID: 29653212.
      View in: PubMed
    6. Pundole X, Murphy W, Ebede CC, Karim E, Manocha S, Don-Pedro D, Rondon G, Leung CH, Liu S, Du XL, Champlin RE, Lu H. Fracture risk prediction using FRAX in patients following hematopoietic stem cell transplantation. Arch Osteoporos. 2018 Apr 04; 13(1):38. PMID: 29619576.
      View in: PubMed
    7. Murphy W. Making a Better Hematopoietic Stem Cell - Timing Is Everything. N Engl J Med. 2018 01 04; 378(1):89-91. PMID: 29298159.
      View in: PubMed
    8. Canter RJ, Grossenbacher SK, Foltz JA, Sturgill IR, Park JS, Luna JI, Kent MS, Culp WTN, Chen M, Modiano JF, Monjazeb AM, Lee DA, Murphy W. Radiotherapy enhances natural killer cell cytotoxicity and localization in pre-clinical canine sarcomas and first-in-dog clinical trial. J Immunother Cancer. 2017 Dec 19; 5(1):98. PMID: 29254507.
      View in: PubMed
    9. Edwards BJ, Sun M, Zhang X, Holmes HM, Song J, Khalil P, Karuturi M, Shah JB, Dinney CP, Gagel RF, Valero V, Champlin RE, Tripathy D, Murphy W. Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience. Support Care Cancer. 2018 May; 26(5):1561-1568. PMID: 29197959.
      View in: PubMed
    10. Jena PK, Sheng L, Liu HX, Kalanetra KM, Mirsoian A, Murphy W, French SW, Krishnan VV, Mills DA, Wan YY. Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment. Am J Pathol. 2017 Aug; 187(8):1800-1813. PMID: 28711154.
      View in: PubMed
    11. Arzi B, Clark KC, Sundaram A, Spriet M, Verstraete FJM, Walker NJ, Loscar MR, Fazel N, Murphy W, Vapniarsky N, Borjesson DL. Therapeutic Efficacy of Fresh, Allogeneic Mesenchymal Stem Cells for Severe Refractory Feline Chronic Gingivostomatitis. Stem Cells Transl Med. 2017 Aug; 6(8):1710-1722. PMID: 28618186.
      View in: PubMed
    12. Dang PN, Herberg S, Varghai D, Riazi H, Varghai D, McMillan A, Awadallah A, Phillips LM, Jeon O, Nguyen MK, Dwivedi N, Yu X, Murphy W, Alsberg E. Endochondral Ossification in Critical-Sized Bone Defects via Readily Implantable Scaffold-Free Stem Cell Constructs. Stem Cells Transl Med. 2017 Jul; 6(7):1644-1659. PMID: 28661587.
      View in: PubMed
    13. Grossenbacher SK, Aguilar EG, Murphy W. Leveraging natural killer cells for cancer immunotherapy. Immunotherapy. 2017 05; 9(6):487-497. PMID: 28472904.
      View in: PubMed
    14. Sckisel GD, Mirsoian A, Minnar CM, Crittenden M, Curti B, Chen JQ, Blazar BR, Borowsky AD, Monjazeb AM, Murphy W. Differential phenotypes of memory CD4 and CD8 T cells in the spleen and peripheral tissues following immunostimulatory therapy. J Immunother Cancer. 2017; 5:33. PMID: 28428882.
      View in: PubMed
    15. Zhang J, Schwartz MP, Hou Z, Bai Y, Ardalani H, Swanson S, Steill J, Ruotti V, Elwell A, Nguyen BK, Bolin J, Stewart R, Thomson JA, Murphy W. A Genome-wide Analysis of Human Pluripotent Stem Cell-Derived Endothelial Cells in 2D or 3D Culture. Stem Cell Reports. 2017 04 11; 8(4):907-918. PMID: 28343999.
      View in: PubMed
    16. Clark KC, Fierro FA, Ko EM, Walker NJ, Arzi B, Tepper CG, Dahlenburg H, Cicchetto A, Kol A, Marsh L, Murphy W, Fazel N, Borjesson DL. Human and feline adipose-derived mesenchymal stem cells have comparable phenotype, immunomodulatory functions, and transcriptome. Stem Cell Res Ther. 2017 03 20; 8(1):69. PMID: 28320483.
      View in: PubMed
    17. Luna JI, Grossenbacher SK, Murphy W, Canter RJ. Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy. Expert Opin Biol Ther. 2017 03; 17(3):313-324. PMID: 27960589.
      View in: PubMed
    18. Park JS, Withers SS, Modiano JF, Kent MS, Chen M, Luna JI, Culp WTN, Sparger EE, Rebhun RB, Monjazeb AM, Murphy W, Canter RJ. Canine cancer immunotherapy studies: linking mouse and human. J Immunother Cancer. 2016; 4:97. PMID: 28031824.
      View in: PubMed
    19. Murphy W. Being "penny-wise but pound foolish" in cancer immunotherapy research: the urgent need for mouse cancer models to reflect human modifying factors. J Immunother Cancer. 2016; 4:88. PMID: 28031818.
      View in: PubMed
    20. Pai CS, Khuat LT, Chen M, Murphy W, Abedi M. Therapeutic Effects of a NEDD8-Activating Enzyme Inhibitor, Pevonedistat, on Sclerodermatous Graft-versus-Host Disease in Mice. Biol Blood Marrow Transplant. 2017 Jan; 23(1):30-37. PMID: 27815049.
      View in: PubMed
    21. Lu H, Champlin RE, Popat U, Pundole X, Escalante CP, Wang X, Qiao W, Murphy W, Gagel RF. Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial. Bonekey Rep. 2016; 5:843. PMID: 28018583.
      View in: PubMed
    22. Xu JY, Murphy W, Milton DR, Jimenez C, Rao SN, Habra MA, Waguespack SG, Dadu R, Gagel RF, Ying AK, Cabanillas ME, Weitzman SP, Busaidy NL, Sellin RV, Grubbs E, Sherman SI, Hu MI. Bone Metastases and Skeletal-Related Events in Medullary Thyroid Carcinoma. J Clin Endocrinol Metab. 2016 12; 101(12):4871-4877. PMID: 27662441.
      View in: PubMed
    23. Minnar CM, Murphy W. Immunoregulatory pathways following strong inflammatory processes markedly impair CD4+ T cell responses. Hum Vaccin Immunother. 2016 09; 12(9):2249-52. PMID: 27409155.
      View in: PubMed
    24. Mamalis A, Koo E, Garcha M, Murphy W, Isseroff RR, Jagdeo J. High fluence light emitting diode-generated red light modulates characteristics associated with skin fibrosis. J Biophotonics. 2016 Dec; 9(11-12):1167-1179. PMID: 27174640.
      View in: PubMed
    25. Grossenbacher SK, Canter RJ, Murphy W. Natural killer cell immunotherapy to target stem-like tumor cells. J Immunother Cancer. 2016; 4:19. PMID: 27096096; PMCID: PMC4835831.
    26. Canter RJ, Grossenbacher SK, Ames E, Murphy W. Immune targeting of cancer stem cells in gastrointestinal oncology. J Gastrointest Oncol. 2016 Apr; 7(Suppl 1):S1-S10. PMID: 27034806; PMCID: PMC4783622.
    27. Monjazeb AM, Kent MS, Grossenbacher SK, Mall C, Zamora AE, Mirsoian A, Chen M, Kol A, Shiao SL, Reddy A, Perks JR, T N Culp W, Sparger EE, Canter RJ, Sckisel GD, Murphy W. Blocking Indolamine-2,3-Dioxygenase Rebound Immune Suppression Boosts Antitumor Effects of Radio-Immunotherapy in Murine Models and Spontaneous Canine Malignancies. Clin Cancer Res. 2016 Sep 01; 22(17):4328-40. PMID: 26979392; PMCID: PMC5010514 [Available on 09/01/17].
    28. Alvarez M, Sun K, Murphy W. Mouse host unlicensed NK cells promote donor allogeneic bone marrow engraftment. Blood. 2016 Mar 03; 127(9):1202-5. PMID: 26738538; PMCID: PMC4778165.
    29. Stolfi JL, Pai CC, Murphy W. Preclinical modeling of hematopoietic stem cell transplantation - advantages and limitations. FEBS J. 2016 05; 283(9):1595-606. PMID: 26640088.
      View in: PubMed
    30. Dang PN, Dwivedi N, Phillips LM, Yu X, Herberg S, Bowerman C, Solorio LD, Murphy W, Alsberg E. Controlled Dual Growth Factor Delivery From Microparticles Incorporated Within Human Bone Marrow-Derived Mesenchymal Stem Cell Aggregates for Enhanced Bone Tissue Engineering via Endochondral Ossification. Stem Cells Transl Med. 2016 Feb; 5(2):206-17. PMID: 26702127; PMCID: PMC4729553.
    31. Arzi B, Mills-Ko E, Verstraete FJ, Kol A, Walker NJ, Badgley MR, Fazel N, Murphy W, Vapniarsky N, Borjesson DL. Therapeutic Efficacy of Fresh, Autologous Mesenchymal Stem Cells for Severe Refractory Gingivostomatitis in Cats. Stem Cells Transl Med. 2016 Jan; 5(1):75-86. PMID: 26582907; PMCID: PMC4704876.
    32. Kheirolomoom A, Ingham ES, Mahakian LM, Tam SM, Silvestrini MT, Tumbale SK, Foiret J, Hubbard NE, Borowsky AD, Murphy W, Ferrara KW. CpG expedites regression of local and systemic tumors when combined with activatable nanodelivery. J Control Release. 2015 Dec 28; 220(Pt A):253-264. PMID: 26471394; PMCID: PMC4688109 [Available on 12/28/16].
    33. Mamalis A, Koo E, Isseroff RR, Murphy W, Jagdeo J. Resveratrol Prevents High Fluence Red Light-Emitting Diode Reactive Oxygen Species-Mediated Photoinhibition of Human Skin Fibroblast Migration. PLoS One. 2015; 10(10):e0140628. PMID: 26488596; PMCID: PMC4619307.
    34. Sckisel GD, Mirsoian A, Bouchlaka MN, Tietze JK, Chen M, Blazar BR, Murphy W. Late administration of murine CTLA-4 blockade prolongs CD8-mediated anti-tumor effects following stimulatory cancer immunotherapy. Cancer Immunol Immunother. 2015 Dec; 64(12):1541-52. PMID: 26423422; PMCID: PMC4782757.
    35. Pellett S, Schwartz MP, Tepp WH, Josephson R, Scherf JM, Pier CL, Thomson JA, Murphy W, Johnson EA. Human Induced Pluripotent Stem Cell Derived Neuronal Cells Cultured on Chemically-Defined Hydrogels for Sensitive In Vitro Detection of Botulinum Neurotoxin. Sci Rep. 2015 Sep 28; 5:14566. PMID: 26411797; PMCID: PMC4585966.
    36. Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, Monjazeb AM, Fragoso RC, Sayers TJ, Murphy W. NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype. J Immunol. 2015 Oct 15; 195(8):4010-9. PMID: 26363055; PMCID: PMC4781667 [Available on 10/15/16].
    37. Mall C, Sckisel GD, Proia DA, Mirsoian A, Grossenbacher SK, Pai CS, Chen M, Monjazeb AM, Kelly K, Blazar BR, Murphy W. Repeated PD-1/PD-L1 monoclonal antibody administration induces fatal xenogeneic hypersensitivity reactions in a murine model of breast cancer. Oncoimmunology. 2016 Feb; 5(2):e1075114. PMID: 27057446.
      View in: PubMed
    38. Zamora AE, Grossenbacher SK, Aguilar EG, Murphy W. Models to Study NK Cell Biology and Possible Clinical Application. Curr Protoc Immunol. 2015 Aug 03; 110:14.37.1-14. PMID: 26237009.
      View in: PubMed
    39. Sckisel GD, Bouchlaka MN, Monjazeb AM, Crittenden M, Curti BD, Wilkins DE, Alderson KA, Sungur CM, Ames E, Mirsoian A, Reddy A, Alexander W, Soulika A, Blazar BR, Longo DL, Wiltrout RH, Murphy W. Out-of-Sequence Signal 3 Paralyzes Primary CD4(+) T-Cell-Dependent Immunity. Immunity. 2015 Aug 18; 43(2):240-50. PMID: 26231116; PMCID: PMC4770886.
    40. Ames E, Canter RJ, Grossenbacher SK, Mac S, Smith RC, Monjazeb AM, Chen M, Murphy W. Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells. Oncoimmunology. 2015 Sep; 4(9):e1036212. PMID: 26405602.
      View in: PubMed
    41. Erdembileg A, Mirsoian A, Enkhmaa B, Zhang W, Beckett LA, Murphy W, Berglund LF. Attenuated age-impact on systemic inflammatory markers in the presence of a metabolic burden. PLoS One. 2015; 10(3):e0121947. PMID: 25815855; PMCID: PMC4376898.
    42. Mirsoian A, Murphy W. Obesity and cancer immunotherapy toxicity. Immunotherapy. 2015; 7(4):319-22. PMID: 25917623; PMCID: PMC4787259.
    43. Mirsoian A, Bouchlaka MN, Sckisel GD, Chen M, Pai CC, Maverakis E, Spencer RG, Fishbein KW, Siddiqui S, Monjazeb AM, Martin B, Maudsley S, Hesdorffer C, Ferrucci L, Longo DL, Blazar BR, Wiltrout RH, Taub DD, Murphy W. Adiposity induces lethal cytokine storm after systemic administration of stimulatory immunotherapy regimens in aged mice. J Exp Med. 2014 Nov 17; 211(12):2373-83. PMID: 25366964; PMCID: PMC4235633.
    44. Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Li CS, Borys D, Smith RC, Tellez J, Sayers TJ, Monjazeb AM, Murphy W. Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma. BMC Cancer. 2014 Oct 10; 14:756. PMID: 25301268; PMCID: PMC4200119.
    45. Ames E, Murphy W. The authors' reply. Transplantation. 2014 Sep 15; 98(5):e39-40. PMID: 25171530; PMCID: PMC4343530.
    46. Monjazeb AM, Tietze JK, Grossenbacher SK, Hsiao HH, Zamora AE, Mirsoian A, Koehn B, Blazar BR, Weiss JM, Wiltrout RH, Sckisel GD, Murphy W. Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help. PLoS One. 2014; 9(8):e102709. PMID: 25119341; PMCID: PMC4131875.
    47. Browne SM, Daud H, Murphy W, Al-Rubeai M. Measuring dissolved oxygen to track erythroid differentiation of hematopoietic progenitor cells in culture. J Biotechnol. 2014 Oct 10; 187:135-8. PMID: 25107508.
      View in: PubMed
    48. Pai CC, Hsiao HH, Sun K, Chen M, Hagino T, Tellez J, Mall C, Blazar BR, Monjazeb A, Abedi M, Murphy W. Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels. Biol Blood Marrow Transplant. 2014 Dec; 20(12):1899-904. PMID: 25064746; PMCID: PMC4254314.
    49. Alvarez M, Bouchlaka MN, Sckisel GD, Sungur CM, Chen M, Murphy W. Increased antitumor effects using IL-2 with anti-TGF-ß reveals competition between mouse NK and CD8 T cells. J Immunol. 2014 Aug 15; 193(4):1709-16. PMID: 25000978; PMCID: PMC4241855.
    50. Murphy W, McDevitt TC, Engler AJ. Materials as stem cell regulators. Nat Mater. 2014 Jun; 13(6):547-57. PMID: 24845994; PMCID: PMC4163547.
    51. Perez-Cunningham J, Ames E, Smith RC, Peter AK, Naidu R, Nolta JA, Murphy W. Natural killer cell subsets differentially reject embryonic stem cells based on licensing. Transplantation. 2014 May 27; 97(10):992-8. PMID: 24704665.
      View in: PubMed
    52. Yu X, Takayama T, Goel SA, Shi X, Zhou Y, Kent KC, Murphy W, Guo LW. A rapamycin-releasing perivascular polymeric sheath produces highly effective inhibition of intimal hyperplasia. J Control Release. 2014 Oct 10; 191:47-53. PMID: 24852098; PMCID: PMC4156896.
    53. Sckisel GD, Tietze JK, Zamora AE, Hsiao HH, Priest SO, Wilkins DE, Lanier LL, Blazar BR, Baumgarth N, Murphy W. Influenza infection results in local expansion of memory CD8(+) T cells with antigen non-specific phenotype and function. Clin Exp Immunol. 2014 Jan; 175(1):79-91. PMID: 23937663; PMCID: PMC3898557.
    54. Sungur CM, Murphy W. Positive and negative regulation by NK cells in cancer. Crit Rev Oncog. 2014; 19(1-2):57-66. PMID: 24941373; PMCID: PMC4242411.
    55. Hou Z, Zhang J, Schwartz MP, Stewart R, Page CD, Murphy W, Thomson JA. A human pluripotent stem cell platform for assessing developmental neural toxicity screening. Stem Cell Res Ther. 2013; 4 Suppl 1:S12. PMID: 24565336; PMCID: PMC3983661.
    56. Bouchlaka MN, Murphy W. Impact of aging in cancer immunotherapy: The importance of using accurate preclinical models. Oncoimmunology. 2013 Dec 01; 2(12):e27186. PMID: 24498569.
      View in: PubMed
    57. Abedi M, Murphy W. The path(way) less traveled. Blood. 2013 Sep 19; 122(12):1996-7. PMID: 24052539.
      View in: PubMed
    58. Ames E, Murphy W. Advantages and clinical applications of natural killer cells in cancer immunotherapy. Cancer Immunol Immunother. 2014 Jan; 63(1):21-8. PMID: 23989217; PMCID: PMC3880590.
    59. Monjazeb AM, Zamora AE, Grossenbacher SK, Mirsoian A, Sckisel GD, Murphy W. Immunoediting and antigen loss: overcoming the achilles heel of immunotherapy with antigen non-specific therapies. Front Oncol. 2013; 3:197. PMID: 23898464; PMCID: PMC3724213.
    60. Sungur CM, Tang-Feldman YJ, Zamora AE, Alvarez M, Pomeroy C, Murphy W. Murine NK-cell licensing is reflective of donor MHC-I following allogeneic hematopoietic stem cell transplantation in murine cytomegalovirus responses. Blood. 2013 Aug 22; 122(8):1518-21. PMID: 23818546; PMCID: PMC3750345.
    61. Alvarez M, Sungur CM, Ames E, Anderson SK, Pomeroy C, Murphy W. Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance. J Immunol. 2013 Jul 15; 191(2):688-98. PMID: 23752612; PMCID: PMC3733663.
    62. Sungur CM, Tang-Feldman YJ, Ames E, Alvarez M, Chen M, Longo DL, Pomeroy C, Murphy W. Murine natural killer cell licensing and regulation by T regulatory cells in viral responses. Proc Natl Acad Sci U S A. 2013 Apr 30; 110(18):7401-6. PMID: 23589894; PMCID: PMC3645578.
    63. Hughes GM, Gang L, Murphy W, Higgins DG, Teeling EC. Using Illumina next generation sequencing technologies to sequence multigene families in de novo species. Mol Ecol Resour. 2013 May; 13(3):510-21. PMID: 23480365.
      View in: PubMed
    64. Westin JR, Thompson MA, Cataldo VD, Fayad LE, Fowler N, Fanale MA, Neelapu S, Samaniego F, Romaguera J, Shah J, McLaughlin P, Pro B, Kwak LW, Sanjorjo P, Murphy W, Jimenez C, Toth B, Dong W, Hagemeister FB. Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. Clin Lymphoma Myeloma Leuk. 2013 Apr; 13(2):99-105. PMID: 23276888; PMCID: PMC3881262.
    65. Koepsel JT, Loveland SG, Schwartz MP, Zorn S, Belair DG, Le NN, Murphy W. A chemically-defined screening platform reveals behavioral similarities between primary human mesenchymal stem cells and endothelial cells. Integr Biol (Camb). 2012 Dec; 4(12):1508-21. PMID: 23147838; PMCID: PMC3543770.
    66. Lu Y, Lee JS, Nemke B, Graf BK, Royalty K, Illgen R, Vanderby R, Markel MD, Murphy W. Coating with a modular bone morphogenetic peptide promotes healing of a bone-implant gap in an ovine model. PLoS One. 2012; 7(11):e50378. PMID: 23185610; PMCID: PMC3503930.
    67. Sckisel GD, Murphy W. Specificity may be overrated in cancer immunotherapy: Getting to know the nonspecific side of memory T Cells. Oncoimmunology. 2012 Oct 01; 1(7):1208-1210. PMID: 23170282.
      View in: PubMed
    68. Sun K, Hsiao HH, Li M, Ames E, Bouchlaka M, Welniak LA, Hagino T, Jagdeo J, Pai CC, Chen M, Blazar BR, Abedi M, Murphy W. IFN-? receptor-deficient donor T cells mediate protection from graft-versus-host disease and preserve graft-versus-tumor responses after allogeneic bone marrow transplantation. J Immunol. 2012 Aug 15; 189(4):2033-42. PMID: 22778394; PMCID: PMC3509544.
    69. Monjazeb AM, Hsiao HH, Sckisel GD, Murphy W. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer. J Immunotoxicol. 2012 Jul-Sep; 9(3):248-58. PMID: 22734880.
      View in: PubMed
    70. Murphy W, Nolta JA. Autoimmune T cells lured to a FASL web of death by MSCs. Cell Stem Cell. 2012 May 04; 10(5):485-7. PMID: 22560070.
      View in: PubMed
    71. Tietze JK, Wilkins DE, Sckisel GD, Bouchlaka MN, Alderson KL, Weiss JM, Ames E, Bruhn KW, Craft N, Wiltrout RH, Longo DL, Lanier LL, Blazar BR, Redelman D, Murphy W. Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy. Blood. 2012 Mar 29; 119(13):3073-83. PMID: 22251483; PMCID: PMC3321869.
    72. Murphy W, Parham P, Miller JS. NK cells--from bench to clinic. Biol Blood Marrow Transplant. 2012 Jan; 18(1 Suppl):S2-7. PMID: 22226108; PMCID: PMC3260456.
    73. Murphy W, Knutson LV, Chapman EG, Mc Donnell RJ, Williams CD, Foote BA, Vala JC. Key aspects of the biology of snail-killing Sciomyzidae flies. Annu Rev Entomol. 2012; 57:425-47. PMID: 22149268.
      View in: PubMed
    74. Sun K, Alvarez M, Ames E, Barao I, Chen M, Longo DL, Redelman D, Murphy W. Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing. Blood. 2012 Feb 09; 119(6):1590-8. PMID: 22184406; PMCID: PMC3286220.
    75. Ames E, Harouna S, Meyer C, Welniak LA, Murphy W. The triterpenoid CDDO-Me promotes hematopoietic progenitor expansion and myelopoiesis in mice. Biol Blood Marrow Transplant. 2012 Mar; 18(3):396-405. PMID: 22100978; PMCID: PMC3502000.
    76. Tietze JK, Sckisel GD, Hsiao HH, Murphy W. Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy? Int Rev Immunol. 2011 Oct-Dec; 30(5-6):238-93. PMID: 22053969.
      View in: PubMed
    77. Hudalla GA, Kouris NA, Koepsel JT, Ogle BM, Murphy W. Harnessing endogenous growth factor activity modulates stem cell behavior. Integr Biol (Camb). 2011 Aug; 3(8):832-42. PMID: 21720642; PMCID: PMC3996706.
    78. Zhang N, Molenda JA, Fournelle JH, Murphy W, Sahai N. Effects of pseudowollastonite (CaSiO3) bioceramic on in vitro activity of human mesenchymal stem cells. Biomaterials. 2010 Oct; 31(30):7653-65. PMID: 20674968.
      View in: PubMed
    79. Boehm D, Murphy W, Al-Rubeai M. The effect of mild agitation on in vitro erythroid development. J Immunol Methods. 2010 Aug 31; 360(1-2):20-9. PMID: 20541555.
      View in: PubMed
    80. Ravoori M, Czaplinska AJ, Sikes C, Han L, Johnson EM, Qiao W, Ng C, Cody DD, Murphy W, Do KA, Navone NM, Kundra V. Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model. PLoS One. 2010 Mar 29; 5(3):e9854. PMID: 20360964; PMCID: PMC2847943.
    81. Hayden S, Bekaert M, Crider TA, Mariani S, Murphy W, Teeling EC. Ecological adaptation determines functional mammalian olfactory subgenomes. Genome Res. 2010 Jan; 20(1):1-9. PMID: 19952139; PMCID: PMC2798820.
    82. Murphy W, Artz AS, Champlin RE, Koreth J, Longo DL, van den Brink MR. Blood stem cell transplantation in older patients. Biol Blood Marrow Transplant. 2009 Dec; 15(12):1638-9. PMID: 19911448.
      View in: PubMed
    83. Boehm D, Murphy W, Al-Rubeai M. The potential of human peripheral blood derived CD34+ cells for ex vivo red blood cell production. J Biotechnol. 2009 Oct 26; 144(2):127-34. PMID: 19735679.
      View in: PubMed
    84. Teeling EC, Springer MS, Madsen O, Bates P, O'brien SJ, Murphy W. A molecular phylogeny for bats illuminates biogeography and the fossil record. Science. 2005 Jan 28; 307(5709):580-4. PMID: 15681385.
      View in: PubMed
    85. Murphy W, Hsiong S, Richardson TP, Simmons CA, Mooney DJ. Effects of a bone-like mineral film on phenotype of adult human mesenchymal stem cells in vitro. Biomaterials. 2005 Jan; 26(3):303-10. PMID: 15262472.
      View in: PubMed
    86. Sun L, Fuselier JA, Murphy W, Coy DH. Antisense peptide nucleic acids conjugated to somatostatin analogs and targeted at the n-myc oncogene display enhanced cytotoxity to human neuroblastoma IMR32 cells expressing somatostatin receptors. Peptides. 2002 Sep; 23(9):1557-65. PMID: 12217415.
      View in: PubMed
    87. Rajeswaran WG, Murphy W, Taylor JE, Coy DH. Exploration of the DTrp-NMeLys motif in the search for potent somatostatin antagonists. Bioorg Med Chem. 2002 Jun; 10(6):2023-9. PMID: 11937362.
      View in: PubMed